BROWSE·page 574 of 601

Browse EX-10 agreements

7,207 total material contract exhibits.



Exhibit 10.1

SILEXION THERAPEUTICS CORP

May 15, 2026

Holder of Ordinary Share Purchase Warrants

Re: Inducement Offer to Exercise Ordinary Share Purchase Warrants

Dear Holder:

Silexion Therapeutics Corp (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) (i) the opportunity to receive new warrants to purchase ordinary shares of the Company, par value $0.0135 per share (the “Ordinary Shares”) and (ii) a reduction in the Exercise Price (as defined in the respective Existing Warrants) of the Ordinary Share purchase warrants issued on August 1, 2025 (the “August Existing Warrants”), the Series A Ordinary Share purchase warrants issued on September 12, 2025 (the “Series A Existing Warrants”), and Series B Ordinary Share purchase warrants issued on September 12, 2025 (the “Series B Existing Warrants”) set forth on Exhibit A hereto (collectively, the “Existing Warrants”) held by you in consideration for exercising by you

EX-10.1·8-K·CIK 2022416·ACC 0001178913-26-002739·Filed May 17, 2026, 15:12 EDT

EX-10.5

EX-10.5

Execution Version

ASSET REPRESENTATIONS REVIEW AGREEMENT

among

GM FINANCIAL AUTOMOBILE LEASING TRUST 2026-2,

as Issuer

GM FINANCIAL,

as Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,

as Asset Representations Reviewer

Dated as of April 1, 2026


TABLE OF CONTENTS

ARTICLE I DEFINITIONS 1
Section 1.1. Definitions 1
Section 1.2. Additional Definitions 1
ARTICLE II ENGAGEMENT OF ASSET REPRESENTATIONS REVIEWER 2
Section 2.1. Engagement; Acceptance 2
Section 2.2. Confirmation of Status 2
ARTICLE III ASSET REPRESENTATIONS REVIEW PROCESS 3
Section 3.1. Asset Review Notices 3
Section 3.2. Identification of Asset Review Receivables 3
Section 3.3. Asset Review Materials 3
Section 3.4. Performance of Asset Reviews 3
Section 3.5. Asset Review Reports 4

EX-10.5·8-K·CIK 2120825·ACC 0001193125-26-226901·Filed May 17, 2026, 15:12 EDT

EX-10.4

EX-10.4

Execution Version

ACAR LEASING LTD.,

as the Titling Trust

GM FINANCIAL,

as Servicer

APGO TRUST,

as Settlor

and

COMPUTERSHARE TRUST COMPANY, N.A.,

as Indenture Trustee and Collateral Agent

2026-2 SERVICING SUPPLEMENT

Dated as of April 1, 2026


TABLE OF CONTENTS

Page
ARTICLE I DEFINITIONS AND INTERPRETIVE PROVISIONS 1
SECTION 1.1. General Definitions 1
ARTICLE II SERVICING OF 2026-2 DESIGNATED POOL 2
SECTION 2.1. Servicing of 2026-2 Designated Pool 2
SECTION 2.2. Identification of 2026-2 Lease Agreements and 2026-2 Leased Vehicles; Securitization Value 2
SECTION 2.3. Accounts 2
SECTION 2.4. General Provisions Regarding Accounts 4

EX-10.4·8-K·CIK 2120825·ACC 0001193125-26-226901·Filed May 17, 2026, 15:12 EDT

EX-10.2

EX-10.2

Execution Version

GMF LEASING LLC,

as Transferor,

and

GM FINANCIAL AUTOMOBILE LEASING TRUST 2026-2,

as Transferee

2026-2 EXCHANGE NOTE TRANSFER AGREEMENT

Dated as of April 1, 2026


TABLE OF CONTENTS

Page
ARTICLE I DEFINITIONS 2
SECTION 1.1. Definitions 2
ARTICLE II TRANSFER OF THE TRANSFERRED ASSETS 2
SECTION 2.1. Transfer of the Transferred Assets. 2
SECTION 2.2. True Sale 3
SECTION 2.3. Representations and Warranties of the Transferor and the Transferee. 4
SECTION 2.4. Financing Statements and Books and Records. 7
SECTION 2.5. Covenants of the Transferor 7
SECTION 2.6. Acceptance by the Transferee 8
ARTICLE III CONDITIONS 8

EX-10.2·8-K·CIK 2120825·ACC 0001193125-26-226901·Filed May 17, 2026, 15:12 EDT

EX-10.1

EX-10.1

Execution Version

GM FINANCIAL,

as Lender

and

GMF LEASING LLC,

as Depositor

2026-2 EXCHANGE NOTE SALE AGREEMENT

Dated as of April 1, 2026


TABLE OF CONTENTS

Page
ARTICLE I DEFINITIONS 2
SECTION 1.1. Definitions 2
ARTICLE II TRANSFER OF THE CONVEYED ASSETS 2
SECTION 2.1. Transfer of the Conveyed Assets 2
SECTION 2.2. True Sale 3
SECTION 2.3. Representations and Warranties of the Lender and the Depositor 4
SECTION 2.4. Financing Statements and Books and Records 7
SECTION 2.5. Affirmative Covenants of the Lender 7
SECTION 2.6. Acceptance by the Depositor 8
ARTICLE III CONDITIONS 8

EX-10.1·8-K·CIK 2120825·ACC 0001193125-26-226901·Filed May 17, 2026, 15:12 EDT

EX-10.2

EX-10.2

Exhibit 10.2

REGISTRATION RIGHTS AGREEMENT

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May [__], 2026, by and between NEXGEL, INC., a Delaware corporation (the “Company”), and the persons and/or entities (each individually a “Buyer” and collectively the “Buyers”) named on the Schedule of Buyers attached to the Purchase Agreement (as defined below). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and between the parties hereto, dated as of May [__], 2026 (the “Purchase Agreement”).

WHEREAS:

EX-10.2·8-K·CIK 1468929·ACC 0001493152-26-023851·Filed May 17, 2026, 15:12 EDT

EX-10.1

EX-10.1

Exhibit 10.1

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May [__], 2026, by and between NEXGEL, INC., a Delaware corporation, with headquarters located at 2150 Cabot Blvd West, Suite B, Langhorne, PA 19047 (the “Company”), and the persons and/or entities (each individually a “Buyer” and collectively the “Buyers”) named on the Schedule of Buyers attached hereto (the “Schedule of Buyers”).

WHEREAS:

A. The Company and each Buyer are executing and delivering this Agreement in reliance upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”) and Rule 506(b) of Regulation D as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the 1933 Act;

EX-10.1·8-K·CIK 1468929·ACC 0001493152-26-023851·Filed May 17, 2026, 15:12 EDT

EX-10.1

EX-10.1

EXECUTION VERSION

AMENDMENT NO. 1 TO GUARANTEE AGREEMENT

AMENDMENT NO. 1 TO GUARANTEE AGREEMENT, dated as of May 14, 2026 (this

“Amendment”), between LUMENT FINANCE TRUST, INC., a Maryland corporation (the “Guarantor”) and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, a national banking association (the “Buyer”) and agreed and acknowledged by LCMT WAREHOUSE, LLC, a Delaware limited liability company (the “Seller”) solely with respect to Sections 2 and 4. Capitalized terms used but not otherwise defined herein shall have the meanings given to them in the Guarantee Agreement (as defined below).

RECITALS

WHEREAS, the Guarantor and Buyer are parties to that certain Guarantee Agreement, dated as of November 3, 2025 (as amended hereby and as further amended, restated, supplemented or otherwise modified and in effect from time to time, the “Guarantee”);

WHEREAS, the Seller and Buyer are parties to that certain Master Repurchase Agreement, dated as of November 3, 2025 (as amended, restated, supplemented or otherwise modified from time to time, the “Repurchase Agreement”);

EX-10.1·10-Q·CIK 1547546·ACC 0001547546-26-000012·Filed May 17, 2026, 15:12 EDT

EX-10.3

EX-10.3

Exhibit 10.3

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

March 16th 2026

Awaysis Belize Limited

3301 Chetumal Street

Belize City, Belize

Guarantors: Yacht Club Resorts development Company Limited, Mr. Michael Singh, Mr. Andrew Trumbach

Dear Clients,

The Belize Bank Limited hereinafter referred to as the “Bank”) is pleased to advise that we will make available to Awaysis Belize Limited (the “Borrower”), the following credit facility/facilities on the terms and conditions outlined below and in Schedule A (General Terms and Conditions), Schedule B (Conditions Precedent), Schedule C (Security Documents), and Schedule D (Form of Acceptance) of this facility letter agreement (hereinafter this facility letter together with Schedule A, Schedule B, Schedule C and Schedule D shall collectively be referred to as “the Agreement”):

CREDIT A: Loan Facility

EX-10.3·10-Q·CIK 1021917·ACC 0001493152-26-023863·Filed May 17, 2026, 15:11 EDT

EX-10.4

EX-10.4

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

brainstorm cell therapeutics inc.

Warrant Shares: Issue Date: , 2026

EX-10.4·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.3

EX-10.3

Exhibit 10.3

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of May ___, 2026 between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

EX-10.3·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.2

EX-10.2

THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.

THE ISSUE PRICE OF THIS NOTE IS $151,800.00

THE ORIGINAL ISSUE DISCOUNT IS $19,800.00

Principal Amount: $151,800.00****Purchase Price: $132,000.00 Issue Date: May 11, 2026

PROMISSORY NOTE

EX-10.2·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT